Loading...
You are here:  Home  >  Health  >  Current News

Novartis’s LEE011 gets FDA fast track in advanced breast cancer



ZURICH (Reuters) - The U.S. Food and Drug Administration has granted priority review status for Novartis drug LEE011 (ribociclib) as a first-line treatment of postmenopausal women with hormone-receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) advanced or metastatic breast cancer in combination with letrozole, the Swiss drugmaker said on Tuesday.


Other News

Olympic medals prospect Kenya causes stir in weighing Zika and Rio NAIROBI (Reuters) - Kenya, with its stellar medal prospects for the Rio Games, caused a stir on Tuesday when the head of its Olympics committee said...
Jury orders DuPont to pay $10.5 million in punitive damages over leaked chemical (Reuters) - A U.S. jury in Ohio ordered DuPont on Thursday to pay $10.5 million in punitive damages to a man who said he developed testicular cancer...
CDC probes multistate listeria outbreak linked to contaminated cheese (Reuters) - The U.S. Centers for Disease Control and Prevention (CDC) is investigating a multistate outbreak of listeriosis linked to the consumptio...

Found news:

Loading...

You might also like...

China confirms bird flu outbreak at poultry farms in central province

Read More →